Sign in
4

Changes in Ownership

Pharvaris N.V. Filed Acc 0001193125-26-288838

Chief Medical Officer sold 29,700 shares at an average $34.30 ($1,018,832)

  • Chief Medical Officer acquired 29,700 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lu Peng · Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-25 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $2.59 $38,850 80,631 D
2026-06-25 Sale : show line 2 in the form 10b5-1 −11,600 $34.45 $399,675 69,031 D
2026-06-25 Sale : show line 3 in the form 10b5-1 −3,400 $35.09 $119,310 65,631 D
2026-06-26 Exercise or conversion : show line 4 in the form 10b5-1 +14,700 $2.59 $38,073 80,331 D
2026-06-26 Sale : show line 5 in the form 10b5-1 −14,700 $34.00 $499,847 65,631 D
Open-market sales · 29,700 sh · avg $34.30 · $1,018,832

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-25 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −15,000 190,008 D
2026-06-26 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −14,700 175,308 D
Loading xslF345X06/ownership.xml…